• LAST PRICE
    0.0300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0300
  • Day Range
    ---
  • 52 Week Range
    Low 11.5300
    ---
    High 15.8900
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMACK
Merrimack Pharmaceuticals Inc
223.7M
-0.3x
---
United StatesRANI
Rani Therapeutics Holdings Inc
223.9M
-3.4x
---
United StatesPYXS
Pyxis Oncology Inc
224.4M
-2.7x
---
United StatesPRLD
Prelude Therapeutics Inc
224.7M
-2.2x
---
United StatesIVVD
Invivyd Inc
230.3M
-1.0x
---
United StatesELYM
Eliem Therapeutics Inc
215.6M
-13.9x
---
As of 2024-05-27

Company Information

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets. It is entitled to receive payments related to its sale of ONIVYDE to Ipsen S.A. and also its contingent payments related to its sale of MM-121 and MM-111 to Elevation Oncology, Inc. These payments are payable by Ipsen upon approval by the United States Food and Drug Administration (FDA) of Onivyde for certain additional clinical indications. ONIVYDE is approved by FDA to market as a first-line treatment of metastatic adenocarcinoma on the pancreas. It is also entitled to receive payments related to its sale of anti-HER3 programs to Elevation Oncology, Inc. The Company’s wholly owned subsidiaries include Merrimack Pharmaceuticals UK Limited and Merrimack Securities Corporation.

Contact Information

Headquarters
One Broadway, 14Th FloorCAMBRIDGE, MA, United States 02142
Phone
617-441-1000
Fax
617-491-1386

Executives

Chairman of the Board, President, Treasurer
Gary Crocker
Independent Director
Eric Andersen
Independent Director
Noah Levy
Independent Director
Ulrik Nielsen
Independent Director
Ana Radeljevic

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$223.7M
Revenue (TTM)
$0.00
Shares Outstanding
14.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.40
EPS
$-0.09
Book Value
$1.31
P/E Ratio
-0.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.